Systems and methods for removing retained fluids and infusing therapeutic fluids

• US 6,132,415 A
• Filed: 02/09/1999
• Issued: 10/17/2000
• Est. Priority Date: 02/09/1999
• Status: Expired due to Term

• Current Assignee: Vasca Inc.
• Original Assignee: Vasca Inc.
• Inventors: Brugger, James M., Burbank, Jeffrey H., Moran, John E., Kuiper, Hendrick K., Wang, John H., Finch, Charles David
• Primary Examiner(s): Yasko, John D.
• Assistant Examiner(s): Blyveis, Deborah
• Application Number:
  US09/248,156
• Time in Patent Office: 616 Days
• Field of Search: 604/502, 604/506, 604/93, 604/175, 604/176, 604/164, 604/30, 604/246, 604/28
• US Class Current: 604/502
• CPC Class Codes: A61M 1/772 operating alternately
• CPC Class Codes: A61M 1/81 Piston pumps, e.g. syringes
• CPC Class Codes: A61M 39/0208 Subcutaneous access sites for injecting or removing fluids transcutaneous access sites A61M39/0247; implantable infusion devices A61M5/14276

Abstract

Systems for draining retained body fluids comprise an implantable port in an access tube. Usually, a drainage cannula for connecting the implantable port to a site of fluid retention is also provided. The implantable port and drainage cannula are implanted subcutaneously with one end of the cannula within the site of fluid retention and the port located remotely from such site. Drainage may then be effected by percutaneously introducing the access tube to the port and optionally applying a vacuum. Kits comprise the implantable port together with instructions for implanting the port as described above. Kits also comprise an access tube with instructions for use for accessing an implanted port as described above.

Claims

1. A method for removing endogenous fluids from a patient, said method comprising:

percutaneously introducing an access tube to an implanted port connected to a site of endogenous fluid retention, wherein the endogenous fluid has accumulated as a result of an abnormal condition; and

removing at least 50% by volume of the endogenous fluid which has accumulated at the site through a fluid conductive path defined by the access tube and the port.

2. A method as in claim 1, wherein removing endogenous fluid comprises applying a vacuum through the access tube.

3. A method as in claim 1, wherein the site is selected from the group consisting of the pleural space, the bladder, the abdomen, and the meninges.

4. A method as in claim 3, wherein the fluid is selected from the group consisting of pleural fluid, urine, ascites, and cerebrospinal fluid.

5. A method as in claim 1, wherein the port is normally closed and opens in response to introduction of the access tube.

6. A method as in claim 1, wherein the access tube is introduced in a direction which is substantially perpendicular to the patient'"'"'s skin at the point where the tube is introduced.

7. A method as in claim 1, further comprising disinfecting the port prior to or after introducing the access tube.

8. A method as in claim 7, wherein disinfecting comprises percutaneously introducing a disinfectant medium to a location in or around the port while the port remains closed.

9. A kit for removing endogenous fluids from a patient, said kit comprising:

an access tube adapted for percutaneous introduction to an implanted port; and

instructions for use setting forth a method for removing endogenous fluids from a patient in accordance with the following steps;

percutaneously introducing an access tube to an implanted port connected to a site of endogenous fluid retention, wherein the endogenous fluid has accumulated as a result of an abnormal condition; and

removing at least 50% by volume of the endogenous fluid which has accumulated at the site through a fluid conductive path defined by the access tube and the port.

10. A kit as in claim 9, further comprising an aspirator which includes the access tube.